In today’s recent session, 33.16 million shares of the CERo Therapeutics Holdings Inc (NASDAQ:CERO) have been traded, and its beta is 0.42. Most recently the company’s share price was $24.58, and it changed around $17.71 or 257.89% from the last close, which brings the market valuation of the company to $12.67M. CERO at last check was trading at a discount to its 52-week high of $895.40, offering almost -3542.8% off that amount. The share price’s 52-week low was $6.71, which indicates that the recent value has risen by an impressive 72.7% since then.

CERo Therapeutics Holdings Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 2 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 1 recommended CERO as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. CERo Therapeutics Holdings Inc is expected to report earnings per share of -10.6 for the current quarter.

CERo Therapeutics Holdings Inc (NASDAQ:CERO) trade information

Instantly CERO has been showing a green trend so far today with a performance of 257.89% on intraday trading today. The performance over the last five days has remained in the green territory. The rise to weekly highs of 17.25 on recent trading daydecreased the stock’s daily price by -42.49%. The company’s shares are currently down -79.52% year-to-date, but still up 234.42% over the last five days. On the other hand, CERo Therapeutics Holdings Inc (NASDAQ:CERO) is 110.09% up in the 30-day period.

CERo Therapeutics Holdings Inc earnings are expected to increase by 73.05% in 2025, but the outlook is positive 57.21% per year for the next five years.

CERO Dividends

CERo Therapeutics Holdings Inc’s next quarterly earnings report is expected to be released in July.